[1]
“CLINICAL AND SUBCLINICAL CHARACTERISTICS ON BREAST CANCER PATIENTS TREATED WITH ANTHRACYCLINES”, YHCĐ, vol. 62, no. 5 (2021), July 2021, doi: 10.52163/yhc.v62i5 (2021).131.